undamentalytics Newsletter

Koru Medical Systems vs Myomo

Koru Medical Systems and Myomo are similar in size: $41.1m and $40.9m of revenue in their latest fiscal years. Myomo grew faster (25.7% against 22.2%). Koru Medical Systems kept more of each dollar of sales as profit: a net margin of -6.4% against -38.1%. Koru Medical Systems carries less debt relative to equity (0.0% against 109.9%).

Latest fiscal yearKoru Medical SystemsKRMD, 2025MyomoMYO, 2025
Revenue $41.1m $40.9m
Revenue growth 22.2% 25.7%
Net income −$2.6m −$15.6m
Operating margin -7.2% -35.2%
Net margin -6.4% -38.1%
Return on equity -15.6% -86.2%
Free cash flow −$470,112 −$16.3m
Cash $8.9m $14.1m
Total debt $0 $12.5m
Debt to equity 0.0% 109.9%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 73 —
Market value $143m $50.6m
Price vs our value range — —
Moat score 46 (Moderate) 33 (Weak)
Insider trades, 12 months 9 buys, 0 sales 13 buys, 8 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.